On the Edge of the Patent Cliff

March 7, 2011 | Pfizer's patent on Lipitor expires in November, representing a $10 billion/year revenue stream for the drug maker. The entire industry is set to lose patents on 10 "megamedicines" this year whose annual sales have neared $50 billion. New York Times